NCCN 2^nd Annual Congress: Hematologic Malignancies – Blood Products and Growth Factors in the Treatment of Thrombocytopenia

Download Podcast

Listen to MP3

Podcast Evaluation

A presentation from the NCCN 2^nd Annual Congress: Hematologic Malignancies™ held September 14-15, 2007, in New York, New York

Presenter

Farhad Ravandi, MD
The University of Texas M. D. Anderson Cancer Center
Houston, Texas

Faculty Disclosure Statement

Dr. Ravandi has disclosed that he has financial interests, arrangements, or affiliations with the manufacturer of products and devices to be discussed in his presentation or who may financially support the educational activity.  He has served as a speaker for Berlex Inc., Genzyme Corporation, and MGI PHARMA, Inc.

Dr. Ravandi has indicated that his presentation will not include discussion of investigational or unlabeled uses of a product.

Program Overview

This presentation will focus on the management of primary and chemotherapy-induced thrombocytopenia in patients with hematologic malignancies, particularly leukemias.  The role of prophylactic platelet transfusions, thrombopoietic cytokines, and novel first- and second-generation thrombopoietic growth factors will be highlighted.

Educational Objectives

Following this activity, participants should be able to:

• Define best practices for the management of thrombocytopenia
• Explain the role of growth factors in the management of chemotherapy-induced thrombocytopenia

Intended Audience

This educational activity is designed to meet the needs of physicians, nurses, and other clinical professionals who manage patients with cancer.

Activity Instructions

Continuing education credit will be awarded to participants who listen to the presentation and complete the evaluation.  Participants should review the learning objectives and faculty disclosure statements prior to listening to a presentation in its entirety.  You must be connected to the Internet in order to review and complete the evaluation form.  A statement of credit will be electronically generated once you complete the evaluation form.  To receive credit, this activity must be completed no later than November 1, 2008.  There is no fee for participating in this activity.

Download Podcast

Listen to MP3

Podcast Evaluation

Accreditation Information

Physicians

The National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians.

NCCN designates this educational activity for a maximum of 0.5 AMA PRA Category 1
Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses

This activity is approved for 0.5 contact hours.  National Comprehensive Cancer Network is an approved provider of continuing nursing education by the PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Approval as a provider refers to recognition of educational activities only and does not imply ANCC Commission on Accreditation or PA Nurses approval or endorsement of any product.

Kristina M. Gregory, RN, MSN, OCN, is our nurse planner for this educational activity.

Release date:  November 1, 2007
Expiration date:  November 1, 2008

Commercial Support

Distribution supported by an educational grant from Amgen